In our study, both PD-1 ligands (i.e., PD-L1 and PD-L2) were expressed by tumor cells from both groups evaluated, with markedly greater positivity for PD-L2, which suggests the functional relevance to this immune checkpoint molecule [55]. This evidence concerns the gene PDCD1LG2 and neoplasm.